FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer-Reference-Cited by-同舟云学术

FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer

Published:2014-01 Issue:1 Volume:50 Page:57-63
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Loupakis F.,Cremolini C.,Salvatore L.,Masi G.,Sensi E.,Schirripa M.,Michelucci A.,Pfanner E.,Brunetti I.,Lupi C.,Antoniotti C.,Bergamo F.,Lonardi S.,Zagonel V.,Simi P.,Fontanini G.,Falcone A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference25 articles.

1. BRAF mutation in metastatic colorectal cancer;Tol;N Engl J Med,2009

2. Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer;Souglakos;Br J Cancer,2009

3. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status;Van Cutsem;J Clin Oncol,2011

4. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study;Bokemeyer;Ann Oncol,2011

5. Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab;Ince;J Natl Cancer Inst,2005

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer: the JSCCR-TRIPON study;International Journal of Clinical Oncology;2024-08-28

2. Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study;British Journal of Surgery;2024-07

3. Reclassification of RAS/BRAF allele mutations predicts the survival benefit of triplet chemotherapy in metastatic colorectal cancer;Therapeutic Advances in Medical Oncology;2024-01

4. Pathologic Features of Primary Colon, Rectal, and Anal Malignancies;Cancer Treatment and Research;2024

5. Axillary cutaneous metastasis of colon cancer with microsatellite instability-high and BRAF V600E mutation treated with curative-intent surgery: a case report;Surgical Case Reports;2023-11-14